Home > Financial Ratios > AJANTA PHARMA

AJANTA PHARMA
Working Capital/Sales

    Back to All Ratios
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

AJANTA PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 4.864.374.252.102.14

What is the latest Working Capital/Sales ratio of AJANTA PHARMA ?

The latest Working Capital/Sales ratio of AJANTA PHARMA is 4.86 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20254.86
Mar20244.37
Mar20234.25
Mar20222.10
Mar20212.14

How is Working Capital/Sales of AJANTA PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 4.86
11.21
Mar2024 4.37
2.82
Mar2023 4.25
102.38
Mar2022 2.1
-1.87
Mar2021 2.14 -

Other Financial Ratios of AJANTA PHARMA


Compare Working Capital/Sales ratio of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹35,015.7 Cr 2.3% -4.4% 4.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


AJANTA PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

2.3%

-4.4%

4.9%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses